Abstract Neutrophil extracellular traps (NETs) are characterized by the presence of extracellular DNA fibers studded with antimicrobial proteins, including myeloperoxidase (MPO). Although NETs play an important role in the innate immune system, the scattered extracellular enzymes, such as MPO, pose risks to the host. Therefore, NETs are strictly regulated by DNase I in the serum, which prevents them from persisting. Recent studies have demonstrated that dysregulation of NETs could be involved in the pathogenesis of autoimmune diseases, including systemic lupus erythematosus. In this review, we interpret the association of disordered NETs with autoimmune diseases, especially propylthiouracil-induced MPO-ANCA-associated vasculitis.
In humans, neutrophils act as the first line of defense against invading microbes. They employ a wide spectrum of antimicrobial strategies, most notably phagocytosis, to eliminate microbes. Subsequent to phagocytosis, neutrophils exhibit a unique style of cell death characterized by the presence of extracellular DNA fibers studded with antimicrobial proteins, including myeloperoxidase (MPO). This mode of cell death, called neutrophil extracellular traps (NETs), is a defense mechanism used by the host to trap and kill invading microbes [1] . NETs function even after the neutrophils are dead.
Dysregulation of NETs in systemic lupus erythematosus
Although NETs play an important role in the innate immune system, there is a risk that antimicrobial enzymes (such as MPO) in the NETs can cause injury to the host tissues. Thus, NETs are strictly regulated by DNase I in the serum, which digests DNA in NETs and prevents them from persisting. A subgroup of patients with systemic lupus erythematosus (SLE) has been reported to poorly digest NETs because of the low activity of DNase I or the presence of DNase I inhibitors, such as anti-DNA antibodies, in the serum [2] . Hakkim et al. suggested that a genetic background with low DNase I activity could lead to the persistence of NETs, and the persistent extracellular DNA in the NETs could be recognized by the host immune system, resulting in the production of anti-DNA antibodies. Furthermore, the anti-DNA antibodies could inhibit the activity of DNase I; therefore, the pathogenesis of SLE mediated by NETs becomes a vicious cycle. patients administered PTU produce MPO-ANCA, and some of them develop MPO-ANCA-associated vasculitis (MPO-AAV). The majority of the PTU is metabolized in the liver, but some of it is modified by MPO in neutrophils [3] .
Propylthiouracil and MPO-ANCA-associated vasculitis

Involvement of disordered NETs induced by PTU in the development of MPO-AAV
Based on the evidence available, we hypothesized that PTU can influence the formation or regulation of NETs and induce MPO-ANCA and subsequently MPO-AAV [4] . First, we examined whether the addition of PTU has an impact on the formation or regulation of NETs in vitro. Widely extended DNA fibers studded with MPO were observed when human neutrophils were treated with phorbol myristate acetate (PMA, Fig. 1a) . On the contrary, treatment of the NETs with PMA and PTU led to DNA fibers with rounded shapes, yielding NETs around the dead neutrophils that were rather limited compared to the NETs obtained when only PMA was added (Fig. 1b) . Interestingly, although the PMA-induced normal NETs were digested by DNase I completely (Fig. 1c) , the abnormal NETs induced by PMA with PTU were barely digested by DNase I (Fig. 1d) . These findings clearly indicate that PTU influences the formation of NETs and their degradation by DNase I.
Next, we examined whether the disordered NETs induced the production of MPO-ANCA in vivo. For this purpose, WKY rats were immunized with abnormal NETs induced by PMA with PTU using rat neutrophils. WKY rats immunized with normal NETs induced by PMA barely produced ANCA; however, WKY rats immunized with abnormal NETs induced by PMA with PTU produced ANCA [4] . Serum reactivity to neutrophils was markedly inhibited by pre-treatment of the neutrophils with anti-MPO antibodies, indicating that the ANCA was MPO-ANCA.
Lastly, we attempted to establish a suitable model for MPO-AAV. For this purpose, WKY rats were given oral PTU and an intraperitoneal injection of PMA. Contrary to the finding that widely extended NETs were observed in the peritoneal tissues of the PMA-injected WKY rats that did not receive PTU (''PMA-treated rats''), NETs in the PMA-injected WKY rats that did receive PTU (''PTU/ PMA-treated rats'') did not extend outward [4] . Furthermore, the area of the NETs in the peritoneal tissues of PTU/PMA-treated rats was significantly larger than that seen in PMA-treated rats. These findings were in accord with the data obtained in vitro, indicating that treatment with PMA and PTU induced an abnormal NET conformation and impaired NET degradation. As expected, MPO-ANCA was produced in the PTU/PMA-treated rats, followed by the development of pauci-immune glomerulonephritis and pulmonary bleeding due to alveolar capillaritis [4] . These findings clearly indicate that PTU induced disordered NETs, MPO-ANCA production, and the subsequent development of MPO-AAV.
Possible implication of disordered NETs in the pathogenesis of MPO-AAV
Abundant NETs have been detected in lesions associated with crescentic glomerulonephritis, and elevated levels of circulating MPO-DNA complexes in the serum-which may derive from in situ NETs-have been observed in patients with MPO-AAV [5] . It has been reported that excessive formation of NETs was induced by influenza virus infection [6] . Although most patients with MPO-AAV are not administered PTU, as yet undetermined environmental factors that act in a similar manner to PTU (such as some infectious agents) can induce NET disorder and trigger MPO-ANCA production, resulting in the development of MPO-AAV (Fig. 2) .
